CS Diagnostics Corp. (CSDX)
Every figure this model derived for CSDX, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2025-09-30.
The figures, and where each came from
This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.
| Figure | Value | XBRL tag | As at |
|---|---|---|---|
| cash | 13 | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents |
2025-09-30 |
| current assets | 31,013 | AssetsCurrent |
2025-09-30 |
| equity | 499,429,404 | StockholdersEquity |
2025-09-30 |
| ocf | -528 | NetCashProvidedByUsedInOperatingActivities |
2025-09-30 |
| revenue | 94,200 | RevenueFromContractWithCustomerIncludingAssessedTax |
2025-09-30 |
The ratios
The figures themselves rather than their scores — what somebody looking up CSDX on one particular measure came for.
| Ratio | Value |
|---|---|
| cash operating margin | 34.06 |
| fcf margin | -0.56 |
| operating margin | 34.06 |
| owner earnings margin | -0.56 |
| revenue growth | -11.45 |
| revenue growth per share | -11.45 |
| rule of 40 | 22.61 |
| sbc pct revenue | 0.0 |
Everything else this filing tags
37 more elements from CSDX's own XBRL that this model has no measure for, newest reading each, largest first. Nothing here is converted, added up or renamed — it is the filing's own element names and the filing's own numbers.
| Element | Newest | As of | Periods | Unit |
|---|---|---|---|---|
AdditionalPaidInCapital | 504,161,838 | 2025-09-30 | 2 | USD |
NetCashProvidedByUsedInInvestingActivities | -499,444,401 | 2024-09-30 | 1 | USD |
PaymentsToAcquireIntangibleAssets | 499,444,401 | 2024-09-30 | 1 | USD |
Assets | 499,431,013 | 2025-09-30 | 2 | USD |
LiabilitiesAndStockholdersEquity | 499,431,013 | 2025-09-30 | 2 | USD |
IntangibleAssetsCurrent | 499,400,000 | 2025-09-30 | 2 | USD |
CommonStockSharesAuthorized | 250,000,000 | 2025-09-30 | 2 | shares |
WeightedAverageNumberOfDilutedSharesOutstanding | 137,430,200 | 2025-09-30 | 4 | shares |
WeightedAverageNumberOfSharesOutstandingBasic | 137,430,200 | 2025-09-30 | 4 | shares |
CommonStockSharesIssued | 137,340,200 | 2025-09-30 | 2 | shares |
CommonStockSharesOutstanding | 137,340,200 | 2025-09-30 | 2 | shares |
OperatingLossCarryforwards | 4,735,847 | 2025-09-30 | 1 | USD |
RetainedEarningsAccumulatedDeficit | -4,735,847 | 2025-09-30 | 2 | USD |
Revenues | 94,200 | 2025-09-30 | 4 | USD |
OperatingExpenses | 62,119 | 2025-09-30 | 4 | USD |
ProfessionalFees | 39,695 | 2025-09-30 | 4 | USD |
NetIncomeLoss | 32,081 | 2025-09-30 | 2 | USD |
NetIncomeLossAvailableToCommonStockholdersBasic | 32,081 | 2025-09-30 | 4 | USD |
OperatingIncomeLoss | 32,081 | 2025-09-30 | 4 | USD |
IncreaseDecreaseInOtherReceivables | 31,000 | 2025-09-30 | 2 | USD |
OtherReceivablesNetCurrent | 31,000 | 2025-09-30 | 1 | USD |
GeneralAndAdministrativeExpense | 22,424 | 2025-09-30 | 4 | USD |
AccountsPayableCurrent | 1,609 | 2025-09-30 | 2 | USD |
IncreaseDecreaseInAccountsPayable | -1,609 | 2025-09-30 | 2 | USD |
Liabilities | 1,609 | 2025-09-30 | 2 | USD |
CommonStockValue | 1,373 | 2025-09-30 | 2 | USD |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | -488 | 2025-09-30 | 2 | USD |
ProfitLoss | -182 | 2025-09-30 | 2 | USD |
NetCashProvidedByUsedInFinancingActivities | 40 | 2025-09-30 | 2 | USD |
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock | 40 | 2025-09-30 | 1 | USD |
Cash | 13 | 2025-09-30 | 2 | USD |
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | 0 | 2025-09-30 | 2 | pure |
CommonStockParOrStatedValuePerShare | 0 | 2025-09-30 | 2 | USD/shares |
CashEquivalentsAtCarryingValue | 0 | 2024-03-31 | 2 | USD |
EarningsPerShareBasic | 0 | 2025-09-30 | 4 | USD/shares |
EarningsPerShareDiluted | 0 | 2025-09-30 | 4 | USD/shares |
ResearchAndDevelopmentExpense | 0 | 2025-09-30 | 2 | USD |
What to be careful about
What this model itself distrusts about CSDX's figures. Written by the derivation as it ran, not added afterwards.
- every figure here comes from one filing (10-Q), so there is no annual report and no history behind it. A company that has just reorganised files under a new registration number, and what it reported before that is not part of this record.
- only 272 days of filings, not a full year: margins and growth are measured, but return on capital and every enterprise-value multiple are refused rather than annualised
- no current stock compensation tagged; treated as zero, so owner earnings are overstated
- no current capital expenditure tagged; treated as zero, so free cash flow is overstated and equals operating cash flow
- no usable diluted share count, so growth is measured on total revenue rather than per share; a company issuing shares to fund that growth reads better than it is
- analyst estimate not used: the consensus itself is a loss
- quality rests on 4 of 5 inputs; not tagged: roic
- valuation DROPPED from the total: only 0 of 2 inputs could be computed (ev ebit, ev owner earnings not tagged), so the score is not meaningful. Its weight is spread over the other dimensions
- durability DROPPED from the total: only 0 of 4 inputs could be computed (worst year, contracted coverage, gross margin stability, cash flow stability not tagged), so the score is not meaningful. Its weight is spread over the other dimensions
- resilience rests on 2 of 3 inputs; not tagged: liquidity
- growth DROPPED from the total: only 1 of 4 inputs could be computed (sustained growth, margin trend, margin recent not tagged), so the score is not meaningful. Its weight is spread over the other dimensions
- 3 of 5 dimensions could not be measured (valuation, durability, growth -- 55% of the model), so this row is not comparable with the others; its total rests on what was left